FDA Approved: POMALYST — Supplemental Application (Celgene Corporation)

View source ↗

Summary

FDA approved a supplemental application for POMALYST (pomalidomide) submitted by Celgene Corporation, resulting in a label change.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Pomalyst (pomalidomide)

Snippet

SUPPL AP for POMALYST (POMALIDOMIDE)